Impact of comorbid conditions on survival in endometrial cancer

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 37, Issue 2, 2014, Pages 131-134

  Nicholas, Zachary ^a   Hu, Nan ^a   Ying, Jian ^a   Soisson, Patrick ^a   Dodson, Mark ^a   Gaffney, David K ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Diabetes; Endometrial cancer; Morbidity; Radiation

Indexed keywords

ESTROGEN;

ABDOMINAL HYSTERECTOMY; ADULT; AGE DISTRIBUTION; ARTICLE; BODY MASS; CANCER GRADING; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; COMORBIDITY; DIABETES MELLITUS; ENDOMETRIUM CANCER; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MENARCHE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PARITY; SMOKING; SURVIVAL RATE; CONFIDENCE INTERVAL; ENDOMETRIAL NEOPLASMS; HYSTERECTOMY; MIDDLE AGED; MORTALITY; RETROSPECTIVE STUDY;

ADULT; BODY MASS INDEX; COMORBIDITY; CONFIDENCE INTERVALS; DIABETES MELLITUS; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; HYPERTENSION; HYSTERECTOMY; MENARCHE; MIDDLE AGED; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 84900488405     PISSN: 02773732     EISSN: 1537453X     Source Type: Journal    
DOI: 10.1097/COC.0b013e318277d5f4     Document Type: Article

References (20)

1. Linkov F, Edwards R, Balk J, et al. Endometrial hyperplasia, endometrial cancer and prevention: gaps in existing research of modifiable risk factors. Eur J Cancer. 2008;44:1632-1644.
2. Haidopoulos D, Simou M, Akrivos N, et al. Risk factors in women 40 years of age and younger with endometrial carcinoma. Acta Obstet Gynecol Scand. 2010;89:1326-1330.
3. Fader AN, Arriba LN, Frasure HE, et al. Endometrial cancer and obesity: epidemiology, biomarkers, prevention and survivorship. Gynecol Oncol. 2009;114:121-127.
4. Brinton LA, Berman ML, Mortel R, et al. Reproductive, menstrual, and medical risk factors for endometrial cancer: results from a case-control study. Am J Obstet Gynecol. 1992;167: 1317-1325.
5. Temkin SM, Pezzullo JC, Hellmann M, et al. Is body mass index an independent risk factor of survival among patients with endometrial cancer? Am J Clin Oncol. 2007;30:8-14.
6. Modesitt SC, Tian C, Kryscio R, et al. Impact of body mass index on treatment outcomes in endometrial cancer patients receiving doxorubicin and cisplatin: a Gynecologic Oncology Group study. Gynecol Oncol. 2007;105:59-65.
7. Kauppila A, Gronroos M, Nieminen U. Clinical outcome in endometrial cancer. Obstet Gynecol. 1982;60:473-480.
8. Chia VM, Newcomb PA, Trentham-Dietz A, et al. Obesity, diabetes, and other factors in relation to survival after endometrial cancer diagnosis. Int J Gynecol Cancer. 2007;17:441-446.
9. Everett E, Tamimi H, Greer B, et al. The effect of body mass index on clinical/pathologic features, surgical morbidity, and outcome in patients with endometrial cancer. Gynecol Oncol. 2003;90: 150-157.
10. Barone BB, Yeh HC, Snyder CF, et al. Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis. JAMA. 2008;300: 2754-2764.
11. Folsom AR, Anderson KE, Sweeney C, et al. Diabetes as a risk factor for death following endometrial cancer. Gynecol Oncol. 2004;94:740-745.
12. Friberg E, Orsini N, Mantzoros CS, et al. Diabetes mellitus and risk of endometrial cancer: a meta-analysis. Diabetologia. 2007;50:1365-1374.
13. Baron JA. Smoking and estrogen-related disease. Am J Epidemiol. 1984;119:9-22.
14. Brown AP, Neeley ES, Werner T, et al. A population-based study of subsequent primary malignancies after endometrial cancer: genetic, environmental, and treatment-related associations. Int J Radiat Oncol Biol Phys. 2010;78:127-135.
15. Meek MD, Finch GL. Diluted mainstream cigarette smoke condensates activate estrogen receptor and aryl hydrocarbon receptor-mediated gene transcription. Environ Res. 1999;80:9-17.
16. Yang HP, Brinton LA, Platz EA, et al. Active and passive cigarette smoking and the risk of endometrial cancer in Poland. Eur J Cancer. 2010;46:690-696.
17. Zhou B, Yang L, Sun Q, et al. Cigarette smoking and the risk of endometrial cancer: a meta-analysis. Am J Med. 2008;121: 501-508, e503.
18. Keys HM, Roberts JA, Brunetto VL, et al. A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study. Gynecol Oncol. 2004;92: 744-751.
19. Creutzberg CL, van Putten WL, Koper PC, et al. Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma. Lancet. 2000;355:1404-1411.
20. Blake P, Swart AM, Orton J, et al. Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): pooled trial results, systematic review, and meta-analysis. Lancet. 2009;373: 137-146.